Olema Pharmaceuticals, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$178.7 | -$142.3 | -$105.0 | -$107.0 | -$71.5 |
| Net income | -$162.5 | -$129.5 | -$96.7 | -$104.8 | -$71.1 |
| Cash Flow Statement | |||||
| Free cash flow | — | -$104.5 | — | -$82.4 | -$52.3 |
Shares outstanding 87.3M · Free float 63.0%
Annual filing data through FY ended December 31, 2025; float as of July 15, 2026.